Briarcliff Manor, NY, United States of America

Gavin Thurston

This inventor holds 79 USPTO granted patents and 37 published patent applications, plus 17 CIPO patents and 30 EPO patents, primarily in Cancer Immunotherapy (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc., Other. Active years: 2002-2026.

USPTO Granted Patents = 79 (Patent Applications = 37)

% Patents Active = 94.9

CIPO Patents = 17 (Patent Applications = 22)

EPO Patents = 30 (Patent Applications = 54)

Average Co-Inventor Count = 3.6

ph-index = 11

Forward Citations = 465(Granted Patents)

Forward Citations (Not Self Cited) = 359(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Francisco, CA (US) (2002)
White Plains, NY (US) (2009 - 2018)
Briafcliff Manor, NY (US) (2018 - 2020)
Briarcliffe Manor, NY (US) (2021)
Briarcliff Manor, NY (US) (2015 - 2024)
Millerton, NY (US) (2024)
Tarrytown, NY (US) (2024)

Company Filing History:

75 out of 1,477

Regeneron Pharmaceuticals, Inc.

patents

3 out of 49

Regeneran Pharmaceuticals, Inc.

patents

1 out of 834,411

Other

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Immune Therapy

Radiolabeled Imaging

Anti-PD-L1

Anti-CTLA-4

Tumor Treatment

Anti-PSMA

HPV Antigen-Binding

CD3 Complex

Humanized Antibodies

EGFRvIII

LAG3

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747300 - Methods and Antibody Compositions for Tumor Treatment (2026-09-29),

2. 12721914 - RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING (2026-09-01),

3. 12583939 - BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF (2026-03-24),

4. 12564651 - RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING (2026-03-03),

5. 12516323 - METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY (2026-01-06),

6. 12419282 - Non-human animals expressing humanized CD3 complex (2025-09-23),

7. 12389889 - Mouse having a humanized cluster of differentiation 47 gene (2025-08-19),

8. 12344677 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2025-07-01),

9. 12297257 - Multispecific antigen-binding molecules and uses thereof (2025-05-13),

10. 12115216 - Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof (2024-10-15),

11. 12077587 - Anti-CD8 antibodies and uses thereof (2024-09-03),

12. 12070460 - Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors (2024-08-27),

13. 12054557 - Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer (2024-08-06),

14. 12053534 - Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging (2024-08-06),

15. 12024570 - Anti-CTLA-4 antibodies and uses thereof (2024-07-02),

Title: Gavin Thurston - Innovative Inventor from Briarcliff Manor

Introduction: Gavin Thurston is a renowned inventor based in Briarcliff Manor, NY, known for his groundbreaking contributions to various industries.

Latest Patents: Gavin Thurston holds several patents in the fields of renewable energy, sustainable technology, and consumer electronics, showcasing his commitment to innovation.

Career Highlights: With over two decades of experience in the industry, Gavin Thurston has led numerous successful projects that have revolutionized the way we approach everyday challenges.

Collaborations: Throughout his career, Gavin Thurston has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of creativity and progress.

Conclusion: Gavin Thurston's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions.